Literature DB >> 17692882

Inhibition of interleukin-6 expression by the V protein of parainfluenza virus 5.

Yuan Lin1, Minghao Sun, Sandra M Fuentes, Celia D Keim, Terri Rothermel, Biao He.   

Abstract

The V protein of parainfluenza virus 5 (PIV5) plays an important role in the evasion of host immune responses. The V protein blocks interferon (IFN) signaling in human cells by causing degradation of the STAT1 protein, a key component of IFN signaling, and blocks IFN-beta production by preventing nuclear translocation of IRF3, a key transcription factor for activating IFN-beta promoter. Interleukin-6 (IL-6), along with tumor necrosis factor (TNF)-alpha and IL-1beta, is a major proinflammatory cytokine that plays important roles in clearing virus infection through inflammatory responses. Many viruses have developed strategies to block IL-6 expression. Wild-type PIV5 infection induces little, if any, expression of cytokines such as IL-6 or TNF-alpha, whereas infection by a mutant PIV5 lacking the conserved C-terminal cysteine rich domain (rPIV5VDeltaC) induced high levels of IL-6 expression. Examination of mRNA levels of IL-6 indicated that the transcription activation of IL-6 played an important role in the increased IL-6 expression. Co-infection with wild-type PIV5 prevented the activation of IL-6 transcription by rPIV5VDeltaC, and a plasmid encoding the full-length PIV5 V protein prevented the activation of IL-6 promoter-driven reporter gene expression by rPIV5VDeltaC, indicating that the V protein played a role in inhibiting IL-6 transcription. The activation of IL-6 was independent of IFN-beta even though rPIV5VDeltaC-infected cells produced IFN-beta. Using reporter gene assays and chromatin immunoprecipitation (ChIP), it was found that NF-kappaB played an important role in activating expression of IL-6. We have proposed a model of activating and inhibiting IL-6 transcription by PIV5.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17692882      PMCID: PMC2100396          DOI: 10.1016/j.virol.2007.07.009

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  49 in total

1.  A study of dogs with kennel cough.

Authors:  I A McCandlish; H Thompson; H J Cornwell; N G Wright
Journal:  Vet Rec       Date:  1978-04-08       Impact factor: 2.695

2.  NP:P and NP:V interactions of the paramyxovirus simian virus 5 examined using a novel protein:protein capture assay.

Authors:  R E Randall; A Bermingham
Journal:  Virology       Date:  1996-10-01       Impact factor: 3.616

3.  Efficient selection for high-expression transfectants with a novel eukaryotic vector.

Authors:  H Niwa; K Yamamura; J Miyazaki
Journal:  Gene       Date:  1991-12-15       Impact factor: 3.688

4.  Measles virus V protein binds zinc.

Authors:  P Liston; D J Briedis
Journal:  Virology       Date:  1994-01       Impact factor: 3.616

5.  The Newcastle disease virus V protein binds zinc.

Authors:  M Steward; A C Samson; W Errington; P T Emmerson
Journal:  Arch Virol       Date:  1995       Impact factor: 2.574

6.  Relationships and host range of human, canine, simian and porcine isolates of simian virus 5 (parainfluenza virus 5).

Authors:  N Chatziandreou; N Stock; D Young; J Andrejeva; K Hagmaier; D J McGeoch; R E Randall
Journal:  J Gen Virol       Date:  2004-10       Impact factor: 3.891

7.  Human T-cell leukemia virus type I Tax activation of NF-kappa B/Rel involves phosphorylation and degradation of I kappa B alpha and RelA (p65)-mediated induction of the c-rel gene.

Authors:  S C Sun; J Elwood; C Béraud; W C Greene
Journal:  Mol Cell Biol       Date:  1994-11       Impact factor: 4.272

8.  High-frequency mutagenesis of human cells and characterization of a mutant unresponsive to both alpha and gamma interferons.

Authors:  R McKendry; J John; D Flavell; M Müller; I M Kerr; G R Stark
Journal:  Proc Natl Acad Sci U S A       Date:  1991-12-15       Impact factor: 11.205

9.  A nuclear factor for IL-6 expression (NF-IL6) is a member of a C/EBP family.

Authors:  S Akira; H Isshiki; T Sugita; O Tanabe; S Kinoshita; Y Nishio; T Nakajima; T Hirano; T Kishimoto
Journal:  EMBO J       Date:  1990-06       Impact factor: 11.598

10.  Two mRNAs that differ by two nontemplated nucleotides encode the amino coterminal proteins P and V of the paramyxovirus SV5.

Authors:  S M Thomas; R A Lamb; R G Paterson
Journal:  Cell       Date:  1988-09-09       Impact factor: 41.582

View more
  14 in total

1.  The measles virus V protein binds to p65 (RelA) to suppress NF-kappaB activity.

Authors:  Kerstin M Schuhmann; Christian K Pfaller; Karl-Klaus Conzelmann
Journal:  J Virol       Date:  2011-01-26       Impact factor: 5.103

2.  Inhibition of interferon regulatory factor 3 activation by paramyxovirus V protein.

Authors:  Takashi Irie; Katsuhiro Kiyotani; Tomoki Igarashi; Asuka Yoshida; Takemasa Sakaguchi
Journal:  J Virol       Date:  2012-04-24       Impact factor: 5.103

3.  Inflammasome Antagonism by Human Parainfluenza Virus Type 3 C Protein.

Authors:  Niraj K Shil; Swechha M Pokharel; Amiya K Banerjee; Michael Hoffman; Santanu Bose
Journal:  J Virol       Date:  2018-01-30       Impact factor: 5.103

4.  Inoculation of swine with foot-and-mouth disease SAP-mutant virus induces early protection against disease.

Authors:  Fayna Díaz-San Segundo; Marcelo Weiss; Eva Pérez-Martín; Camila C Dias; Marvin J Grubman; Teresa de los Santos
Journal:  J Virol       Date:  2011-11-23       Impact factor: 5.103

5.  Attenuation of V- or C-defective measles viruses: infection control by the inflammatory and interferon responses of rhesus monkeys.

Authors:  Patricia Devaux; Gregory Hodge; Michael B McChesney; Roberto Cattaneo
Journal:  J Virol       Date:  2008-04-02       Impact factor: 5.103

6.  Akt plays a critical role in replication of nonsegmented negative-stranded RNA viruses.

Authors:  Minghao Sun; Sandra M Fuentes; Khalid Timani; Dengyun Sun; Chris Murphy; Yuan Lin; Avery August; Michael N Teng; Biao He
Journal:  J Virol       Date:  2007-10-24       Impact factor: 5.103

7.  Recombinant parainfluenza virus 5 vaccine encoding the influenza virus hemagglutinin protects against H5N1 highly pathogenic avian influenza virus infection following intranasal or intramuscular vaccination of BALB/c mice.

Authors:  Alaina J Mooney; Zhuo Li; Jon D Gabbard; Biao He; S Mark Tompkins
Journal:  J Virol       Date:  2012-10-17       Impact factor: 5.103

8.  A single amino acid residue change in the P protein of parainfluenza virus 5 elevates viral gene expression.

Authors:  Khalid A Timani; Dengyun Sun; Minghao Sun; Celia Keim; Yuan Lin; Phuong Tieu Schmitt; Anthony P Schmitt; Biao He
Journal:  J Virol       Date:  2008-07-09       Impact factor: 5.103

9.  Role for the paramyxovirus genomic promoter in limiting host cell antiviral responses and cell killing.

Authors:  Mary J Manuse; Griffith D Parks
Journal:  J Virol       Date:  2009-07-08       Impact factor: 5.103

10.  PLK1 down-regulates parainfluenza virus 5 gene expression.

Authors:  Dengyun Sun; Priya Luthra; Zhuo Li; Biao He
Journal:  PLoS Pathog       Date:  2009-07-24       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.